Der neueste Peer-reviewed Artikel


    J Exp Clin Cancer Res. 2019 Jul 8;38(1):292. doi: 10.1186/s13046-019-1286-9.
    Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
    Richter C, Marquardt S, Li F, Spitschak A, Murr N, Edelhäuser BAH, Iliakis G, Pützer BM, Logotheti S.

Der neueste Buchartikel


    Methods Mol Biol. 2019;1912:33-52. doi: 10.1007/978-1-4939-8982-9_2.
    p73-Governed miRNA Networks: Translating Bioinformatics Approaches to Therapeutic Solutions for Cancer Metastasis.
    Logotheti S, Marquardt S, Pützer BM.

Der neueste Abstract


    New Horizons in Translational Medicine Volume 4;1-4:48-98.
    E2F1 signaling promotes chemoresistance and lymphogenic metastasis in penile cancer revealing new prognostic biomarkers.
    Fenner F, Goody D, Protzel C, Erbersdobler A, Richter C, Hartz J, Naumann CM, Kalthoff H, Herchenröder O, Hakenberg OW, Pützer BM.

Die neueste Abschlussarbeit


    Juliane Marie Hartz (Ärztin)
    Analyse metastasierungsrelevanter microRNAs und deren prognostische Bedeutung für das Peniskarzinom
    Rostock 

... weitere Publikationen


    Cell Death Differ. 2000; 7:177-188.
    E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products.
    Pützer BM, Stiewe T, Parssanedjad K, Rega S, Esche H.
    Drug Res Updates. 2010 Aug-Oct;13(4-5):119-31.
    Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.
    Engelmann D, Pützer BM.
    Tumor Diag Ther. 2000; 21:1-7.
    The Role of Tumor Suppressor Gene Therapy for Anticancer Treatment.
    Pützer BM.